REQUEST A DEMO
Total
USD $0.00
Search more companies

Reliance Life Sciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Reliance Life Sciences Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Reliance Life Sciences Private Limited is a research-driven organization located in Navi Mumbai, India. It is part of the Promoter Group of Reliance Industries Limited. The company focuses on various areas including bio-therapeutics, pharmaceuticals, clinical research services, regenerative medicine, and molecular medicine. Reliance Life Sciences has achieved several milestones in the industry. It has launched five of the world's first biosimilars and has the largest number of biosimilars in the Indian market. The company also has the highest number of biosimilars under development globally. Additionally, Reliance Life Sciences is the first integrated manufacturer of plasma proteins in South Asia. The company has played a significant role in the emergence of regenerative medicine in India and has extensive experience with cord blood stem cell transplants. It also offers a specialized range of tests in molecular medicine and molecular genetics. Reliance Life Sciences has a professional team consisting of Ph.Ds, M.Ds, Engineers, and Post Graduates in Science. The average age of the team is 35 years, and 22% of the employees are women. The company operates state-of-the-art facilities, with the flagship facility being the Dhirubhai Ambani Life Sciences Centre (DALC) in Navi Mumbai. DALC is a diverse and integrated life sciences campus that houses world-scale and world-class manufacturing facilities approved by Indian and international regulatory agencies. Reliance Life Sciences is a fully-integrated player in the life sciences industry, with capabilities in research, pre-clinical and clinical development, process development, quality management, commercial-scale manufacturing, and marketing.

Legal Address
Dhirubhai Ambani Life Sciences Centre R-282 Ttc Area Of Midc, Thane Belapur Road, Rabale
Thane; Maharashtra; Postal Code: 400701

Contact Details: Purchase the Reliance Life Sciences Private Limited report to view the information.

Website: http://www.rellife.com

Basic Information
Total Employees:
Purchase the Reliance Life Sciences Private Limited report to view the information.
Outstanding Shares:
Purchase the Reliance Life Sciences Private Limited report to view the information.
Registered Capital:
Purchase the Reliance Life Sciences Private Limited report to view the information.
Financial Auditors:
Purchase the Reliance Life Sciences Private Limited report to view the information.
Incorporation Date:
January 30, 2001
Key Executives
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Ownership Details
Purchase this report to view the information.
52.07%
Purchase this report to view the information.
41.66%
Purchase this report to view the information.
6.25%
Subsidiaries
Reliance Life Sciences Nashik Private Limited
100%
Company Performance
Financial values in the chart are available after Reliance Life Sciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
25.82%
Total operating revenue
25.91%
Operating profit (EBIT)
27.42%
EBITDA
29.12%
Net Profit (Loss) for the Period
28.2%
Total assets
43.12%
Total equity
61.11%
Operating Profit Margin (ROS)
0.42%
Net Profit Margin
0.45%
Return on Equity (ROE)
-9.69%
Debt to Equity Ratio
-14.4%
Quick Ratio
0.82%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?